In addition to inhibiting the release of pro-angiogenic mediators, our results show that silencing TRAF3IP2 in GBM cells decreases the expression of IL1b, IL6, and IL8, which are proinflammatory and pro-angiogenic (Figure 4). This evidence concerns the gene TRAF3IP2 and glioblastoma.